Silencing of Glutathione S-Transferase Pi Inhibits Cancer Cell Growth via Oxidative Stress Induced by Mitochondria

Naoki Fujitani1, Akihiro Yoneda2, Motoko Takahashi1

  • 1Department of Biochemistry, Sapporo Medical University School of Medicine, S1W17, Sapporo, 060-8556, Japan.

Scientific Reports
|October 16, 2019
PubMed

Insights

Targeting antioxidant enzymes like glutathione S-transferases (GSTs) offers a novel cancer treatment. Suppressing GST P (GSTP) using siRNA induces oxidative stress and impairs cancer cell growth by affecting mitochondria.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Antitumor drug development increasingly focuses on modulating cancer cell antioxidant systems.
  • Glutathione S-transferases (GSTs) are key antioxidant enzymes targeted for cancer therapy.
  • Oxidative stress plays a critical role in cancer progression and treatment resistance.

Purpose of the Study:

  • To investigate the potential of suppressing glutathione S-transferase P (GSTP) as a cancer treatment strategy.
  • To evaluate the effects of GSTP silencing on cancer cell growth and oxidative stress.
  • To explore the underlying mechanisms, including mitochondrial dysfunction, involved in GSTP-silenced cancer cells.

Main Methods:

  • Utilized small interfering RNA (siRNA) for transcriptional silencing of GSTP.
  • Examined the impact of GSTP silencing on cancer cell growth across 13 cancer cell lines.
  • Performed comparative proteomics on normal cells versus GSTP-silenced pancreatic cancer cells (PANC-1).

Main Results:

  • GSTP silencing significantly impaired the growth of various cancer cell lines.
  • Suppression of GSTP led to increased reactive oxygen species (ROS) accumulation and oxidative stress.
  • Comparative proteomics indicated that GSTP silencing induced mitochondrial dysfunction in pancreatic cancer cells.

Conclusions:

  • Genetic silencing of GSTP is a promising strategy for cancer therapy.
  • Modulating oxidative stress via GSTP suppression promotes cancer cell death.
  • Mitochondrial dysfunction is a key mechanism through which GSTP silencing exerts its antitumor effects.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K